Comparative analysis of cytotoxicity, apoptosis, and tumor-progression gene expressions in MCF-7 breast cancer cells treated with Ribociclib, Everolimus, and Doxorubicin: An integrative bioinformatics and experimental study.
- DOI
- 10.1007/s11033-026-13088-9
- Published
- 2026 Nov 10
- Container
- Molecular biology reports
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s11033-026-13088-9,
title = {Comparative analysis of cytotoxicity, apoptosis, and tumor-progression gene expressions in MCF-7 breast cancer cells treated with Ribociclib, Everolimus, and Doxorubicin: An integrative bioinformatics and experimental study.},
author = {Amoei A and Ghotbbahaei M and Barzegar A and Hossein-Nataj H and Lotfi M and Taghiloo S and Asgarian-Omran H},
year = {2026},
journal = {Molecular biology reports},
doi = {10.1007/s11033-026-13088-9},
url = {https://doi.org/10.1007/s11033-026-13088-9}
}RIS
TY - JOUR TI - Comparative analysis of cytotoxicity, apoptosis, and tumor-progression gene expressions in MCF-7 breast cancer cells treated with Ribociclib, Everolimus, and Doxorubicin: An integrative bioinformatics and experimental study. AU - Amoei A AU - Ghotbbahaei M AU - Barzegar A AU - Hossein-Nataj H AU - Lotfi M AU - Taghiloo S AU - Asgarian-Omran H PY - 2026 JO - Molecular biology reports DO - 10.1007/s11033-026-13088-9 UR - https://doi.org/10.1007/s11033-026-13088-9 ER -
APA
A, A., M, G., A, B., H, H., M, L., S, T., & H, A. (2026). Comparative analysis of cytotoxicity, apoptosis, and tumor-progression gene expressions in MCF-7 breast cancer cells treated with Ribociclib, Everolimus, and Doxorubicin: An integrative bioinformatics and experimental study.. Molecular biology reports. https://doi.org/10.1007/s11033-026-13088-9
Source records
- pubmed · retrieved 2026-11-11T04:38:15.683Z